Asset Details
- Identifier:
- 15111_1_doi150027t1
- Description:
- Characteristics of 83 Patients Treated With Pembrolizumab
- License:
- Rights Managed
- Rights Holder:
- JAMA
- License Rights Holder:
- Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
- Asset Type:
- Image
- Asset Subtype:
- Table
- Image Orientation:
- Portrait
- Image Dimensions:
- 1024 x 2464
- Image File Size:
- 521 KB
- Creator:
- Martina Sanlorenzo, Igor Vujic, Adil Daud, Alain Algazi, Matthew Gubens, Sara Alcántara Luna, Kevin Lin, Pietro Quaglino, Klemens Rappersberger, Susana Ortiz-Urda
- Credit:
- Sanlorenzo, M., Vujic, I., Daud, A., Algazi, A., Gubens, M., Luna, S. A., Lin, K., Quaglino, P., Rappersberger, K., & Ortiz-Urda, S. (2015). Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression. JAMA Dermatology, 151(11), 1-7. https://doi.org/10.1001/jamadermatol.2015.1916.
- Collection:
- Keywords:
- Restrictions:
- Property Release:
- No
- Model Release:
- No
- Purchasable:
- Yes
- Sensitive Materials:
- No
- Article Title:
- Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
- Article Authors:
- Martina Sanlorenzo, Igor Vujic, Adil Daud, Alain Algazi, Matthew Gubens, Sara Alcántara Luna, Kevin Lin, Pietro Quaglino, Klemens Rappersberger, Susana Ortiz-Urda
- Article Copyright Year:
- Publication Title:
- JAMA Dermatology
- Publication Volume:
- 151
- Publication Issue:
- 11
- Publication Date:
- 11/11/2015
- DOI:
- https://doi.org/10.1001/jamadermatol.2015.1916
Click on image to enlarge
